D
Cytokinetics, Incorporated CYTK
$38.34 $0.290.76% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments -18.80% 51.58% 75.01% 87.61% 86.80%
Total Receivables -- 141.25% 1,197.74% -90.24% --
Inventory -- -- -- -- --
Prepaid Expenses 81.21% -16.32% 27.90% -66.13% -43.39%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -16.98% 49.69% 76.41% 81.43% 82.04%

Total Current Assets -16.98% 49.69% 76.41% 81.43% 82.04%
Net Property, Plant & Equipment 2.38% -1.08% -4.58% -9.63% -9.60%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 89.52% 62.49% -3.64% -5.64% -7.91%
Total Assets -19.57% 56.43% 70.04% 93.90% 95.38%

Total Accounts Payable 71.36% 7.52% -5.29% -16.06% -24.61%
Total Accrued Expenses 31.40% 8.06% 29.74% 51.20% 26.51%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 13.18% 9.36% 9.76% 76.24% 91.24%
Total Finance Division Other Current Liabilities 21.60% 1,061.96% 486.99% 31.24% 298.76%
Total Other Current Liabilities 21.60% 1,061.96% 486.99% 31.24% 298.76%
Total Current Liabilities 27.52% 79.76% 74.99% 41.29% 56.63%

Total Current Liabilities 27.52% 79.76% 74.99% 41.29% 56.63%
Long-Term Debt 31.60% 26.04% 26.54% 25.30% 5.52%
Short-term Debt -- -- -- -- --
Capital Leases -4.87% -4.39% -6.51% -6.42% -6.22%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -8.47% 26.29% 25.26% 24.93% 76.37%
Total Liabilities 12.66% 27.09% 26.96% 22.94% 27.15%

Common Stock & APIC 5.13% 40.11% 48.56% 64.72% 65.15%
Retained Earnings -25.36% -27.37% -27.91% -29.18% -29.54%
Treasury Stock & Other 84.54% 386.64% 24,080.00% 716.36% 29.90%
Total Common Equity -439.68% 32.75% 64.96% 96.83% 132.59%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -439.68% 32.75% 64.96% 96.83% 132.59%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -439.68% 32.75% 64.96% 96.83% 132.59%